Influence of estrogen on pulmonary arterial hypertension: Role of oxidative stress

Cell Biochemistry and Function

Volumn 29, Issue 7, 2011, Pages 543-548

  Siqueira, R ^a   Campos, C ^a   Colombo, R ^a   Becker, C U ^a   Fernandes, T R G ^a   Araujo A S R ^a   Bello Klein A ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Atrial natriuretic peptide (ANP); Cor pulmonale; Estrogen replacement; Redox balance

Indexed keywords

ESTRADIOL; ESTROGEN; GLUTATHIONE; MONOCROTALINE; SUNFLOWER OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; HEART HEMODYNAMICS; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE PRESSURE; MORPHOMETRICS; NONHUMAN; OVARIECTOMY; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT;

ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; DIESTRUS; ESTRADIOL; FEMALE; GLUTATHIONE; HEART VENTRICLES; HEMODYNAMICS; HYPERTENSION, PULMONARY; MONOCROTALINE; OVARIECTOMY; OXIDATIVE STRESS; PLANT OILS; PULMONARY ARTERY; RATS; RATS, WISTAR;

ANIMALIA; HELIANTHUS; RATTUS; RATTUS NORVEGICUS;

EID: 80053631360     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1784     Document Type: Article

References (36)

1. Chen L, Gan XT, Haist JV, et al. Attenuation of compensatory right ventricular hypertrophy and heart failure following monocrotaline-induced pulmonary vascular injury by the Na+-H+exchange inhibitor cariporide. J Pharmacol Exp Ther 2001; 298(2): 469-476.
2. Chan SY, Loscalzo J. Pathogenic mechanisms of pulmonary arterial hypertension. J Mol Cell Cardiol 2008; 44(1): 14-30.
3. Chin KM, Rubin LJ. Pulmonary arterial hypertension. J Am Coll Cardiol 2008; 51(16): 1527-1538.
4. Lehrman S, Romano P, Frishman W, Rashid A, Dobkin J, Reichel J. Primary pulmonary hypertension and cor pulmonale. Cardiol Rev 2002; 10(5): 265-278.
5. Piao L, Marsboom G, Archer SL. Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure. J Mol Med 2010; 88(10): 1011-1020.
6. Pichardo J, Palace V, Farahmand F, Singal PK. Myocardial oxidative stress changes during compensated right heart failure in rats. Mol Cell Biochem 1999; 196(1-2): 51-57.
7. Yildiz P. Molecular mechanisms of pulmonary hypertension. Clin Chim Acta 2009; 403(1-2): 9-16.
8. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008; 32(5): 1371-1385.
9. Farahmand F, Hill MF, Singal PK. Antioxidant and oxidative stress changes in experimental cor pulmonale. Mol Cell Biochem 2004; 260(1-2): 21-29.
10. Seyfarth T, Gerbershagen HP, Giessler C, et al. The cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in monocrotaline-treated rats. J Mol Cell Cardiol 2000; 32(12): 2315-2326.
11. Doggrell SA, Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res 1998; 39(1): 89-105.
12. Halliwell B, Gutteridge JC. Free Radical in Biology and Medicine. 3 (ed.). Clerendon Press: Oxford, 1999.
13. Tsutsui H, Kinugawa S, Matsushima S. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res 2009; 81(3): 449-456.
14. Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P. Redox regulation of cell survival. Antioxid Redox Signal 2008; 10(8): 1343-1374.
15. do Nascimento GR, Barros YV, Wells AK, Khalil RA. Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease. Curr Hypertens Rev 2009; 5(4): 283-306.
16. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and actions of estrogens. N Engl J Med 2002; 346(5): 340-352.
17. Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev 2008; 60(2): 210-241.
18. Babiker FA, De Windt LJ, van Eickels M, Grohe C, Meyer R, Doevendans PA. Estrogenic hormone action in the heart: regulatory network and function. Cardiovasc Res 2002; 53(3): 709-719.
19. Levin ER. Estrogen receptor-beta and the cardiovascular system. Trends Endocrinol Metab 2002; 13(5): 184-185.
20. Smiley DA, Khalil RA. Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels. Curr Med Chem 2009; 16(15): 1863-1887.
21. Patel KM, Lahm T, Crisostomo PR, et al. The effects of endogenous sex hormones and acute hypoxia on vasoconstriction in isolated rat pulmonary artery rings. J Surg Res 2008; 146(1): 121-126.
22. Campbell SE, Febbraio MA. Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake. Am J Physiol Endocrinol Metab 2002; 282(5): E1139-E1146.
23. Ludke AR, Mosele F, Caron-Lienert R, et al. Modulation of monocrotaline-induced cor pulmonale by grape juice. J Cardiovasc Pharmacol 2010; 55(1): 89-95.
24. Akerboom TP, Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol 1981; 77: 373-382.
25. Araujo AS, Schenkel P, Enzveiler AT, et al. The role of redox signaling in cardiac hypertrophy induced by experimental hyperthyroidism. J Mol Endocrinol 2008; 41(6): 423-430.
26. Klein D, Kern RM, Sokol RZ. A method for quantification and correction of proteins after transfer to immobilization membranes. Biochem Mol Biol Int 1995; 36(1): 59-66.
27. Ahn BH, Park HK, Cho HG, et al. Estrogen and enalapril attenuate the development of right ventricular hypertrophy induced by monocrotaline in ovariectomized rats. J Korean Med Sci 2003; 18(5): 641-648.
28. Tofovic SP, Salah EM, Mady HH, Jackson EK, Melhem MF. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats. J Cardiovasc Pharmacol 2005; 46(4): 430-437.
29. Tofovic SP, Zhang X, Jackson EK, Dacic S, Petrusevska G. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension. Vascul Pharmacol 2006; 45(6): 358-367.
30. Tofovic SP, Zhang X, Zhu H, Jackson EK, Rafikova O, Petrusevska G. 2-Ethoxyestradiol is antimitogenic and attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling. Vascul Pharmacol 2008; 48(4-6): 174-183.
31. Xing D, Nozell S, Chen YF, Hage F, Oparil S. Estrogen and mechanisms of vascular protection. Arterioscler Thromb Vasc Biol 2009; 29(3): 289-295.
32. Souza-Rabbo MP, Silva LF, Auzani JA, Picoral M, Khaper N, Bello-Klein A. Effects of a chronic exercise training protocol on oxidative stress and right ventricular hypertrophy in monocrotaline-treated rats. Clin Exp Pharmacol Physiol 2008; 35(8): 944-948.
33. de Andrade EN, Goncalves GK, de Oliveira TH, et al. Natriuretic peptide system: a link between fat mass and cardiac hypertrophy and hypertension in fat-fed female rats. Regul Pept 2011; 167(1): 149-155.
34. Kilic A, Javadov S, Karmazyn M. Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy. J Mol Cell Cardiol 2009; 46(3): 360-369.
35. Kondo T, Hirose M, Kageyama K. Roles of oxidative stress and redox regulation in atherosclerosis. J Atheroscler Thromb 2009; 16(5): 532-538.
36. Baeza I, Fdez-Tresguerres J, Ariznavarreta C, De la Fuente M. Effects of growth hormone, melatonin, oestrogens and phytoestrogens on the oxidized glutathione (GSSG)/reduced glutathione (GSH) ratio and lipid peroxidation in aged ovariectomized rats. Biogerontology 2010; 11(6): 687-701.